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Gastrointestinal (GI) pain is a common clinical problem, for which effective therapy is quite
limited. Sensations from the GI tract, including pain, are mediated largely by neurons in
the dorsal root ganglia (DRG), and to a smaller extent by vagal afferents emerging from
neurons in the nodose/jugular ganglia. Neurons in rodent DRG become hyperexcitable
in models of GI pain (e.g., gastric or colonic inflammation), and can serve as a source
for chronic pain. Glial cells are another element in the pain signaling pathways, and there
is evidence that spinal glial cells (microglia and astrocytes) undergo activation (gliosis)
in various pain models and contribute to pain. Recently it was found that satellite glial
cells (SGCs), the main type of glial cells in sensory ganglia, might also contribute to
chronic pain in rodent models. Most of that work focused on somatic pain, but in several
studies GI pain was also investigated, and these are discussed in the present review. We
have shown that colonic inflammation induced by dinitrobenzene sulfonic acid (DNBS)
in mice leads to the activation of SGCs in DRG and increases gap junction-mediated
coupling among these cells. This coupling appears to contribute to the hyperexcitability
of DRG neurons that innervate the colon. Blocking gap junctions (GJ) in vitro reduced
neuronal hyperexcitability induced by inflammation, suggesting that glial GJ participate
in SGC-neuron interactions. Moreover, blocking GJ by carbenoxolone and other agents
reduces pain behavior. Similar changes in SGCs were also found in the mouse nodose
ganglia (NG), which provide sensory innervation to most of the GI tract. Following
systemic inflammation, SGCs in these ganglia were activated, and displayed augmented
coupling and greater sensitivity to the pain mediator ATP. The contribution of these
changes to visceral pain remains to be determined. These results indicate that although
visceral pain is unique, it shares basic mechanisms with somatic pain, suggesting that
therapeutic approaches to both pain types may be similar. Future research in this field
should include additional types of GI injury and also other types of visceral pain.
Keywords: dorsal root ganglia, nodose ganglia, chronic pain, colonic inflammation, satellite glial cells, gap
junctions, purinergic receptors
INTRODUCTION
The term ‘‘visceral pain’’ covers a wide range of pain types associated with internal organs located in
the thorax and abdominal cavity. Visceral pain is a major clinical problem and is ‘‘the most frequent
form of pain produced by disease and one of themain reasons for patients to seekmedical attention’’
(Cervero and Laird, 2004). Among the types of visceral pain, gastrointestinal (GI) pain is probably
the most common, and is associated with a large number of GI disorders like gastritis, celiac
disease, pancreatitis, constipation, and biliary tract inflammation. A major group of GI problems
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comprises syndromes known as ‘‘functional GI disorders’’. These
syndromes include irritable bowel disease (IBS) and functional
dyspepsia, and are characterized by pain, but have no identifiable
structural or biochemical abnormalities (Chang et al., 2010).
Patients with inflammatory bowel disease (colitis, Crohn’s)
frequently complain of abdominal pain, which may persist after
the resolution of inflammation, indicating that long term changes
in the nervous system contribute to this post-inflammatory pain
(Bielefeldt et al., 2009; Beyak, 2010). Stimuli that evoke GI pain
can be mechanical, like distension of hollow organs (stomach,
intestine), and traction of the mesentery; or chemical, like acid.
Ischemia and various inflammatory mediators can also cause
visceral pain, or to lower the pain threshold to mechanical
stimuli. For reviews on this topic see Cervero and Laird (2004);
Bielefeldt and Gebhart (2013). The mechanisms underlying
many types of GI pain are far from being understood and pain
management options continue to remain limited (Bielefeldt et al.,
2009).
GI pain is typically diffuse and non-localized and not
necessarily felt at the source of stimulus or injury (Cervero
and Laird, 2004; Bielefeldt and Gebhart, 2013). A well known
example for referred pain is angina pectoris, which is caused by
cardiac hypoxia, and may cause pain in the left arm. A possible
explanation for these and other types of referred pain is that
the nerve supply to these internal organs develops during the
embryonic period from the respective skin regions. Still, this
explanation is far from being mechanistic.
SENSORY GANGLIA AND VISCERAL PAIN
The initial and often driving force for somatic pain is
peripheral injury or inflammation (Devor, 2013), and therefore
understanding peripheral mechanisms should be the focus of
pain research (in distinction from the current emphasis on
central mechanisms). A reasonable working hypothesis is that the
same principle also holds for visceral pain, and clearly sensory
ganglia, which are the first station in the pain pathway, deserve to
be a major subject for studying visceral pain, and are a preferred
target for its treatment. Thus, the account below is devoted to
discussing the involvement in GI pain of neurons and glial cells
in sensory ganglia.
Sensory ganglia contain the cell bodies of primary afferent
neurons, which have a bifurcating axon, with one branch
projecting to the periphery, and the other into the spinal
cord (Figure 1). The main types of sensory ganglia are the
dorsal root ganglia (DRG), which innervate most parts of
the body, including internal organs; the trigeminal ganglia
(TG), which innervate the head, face and teeth, and the
nodose ganglia (NG), which innervate most visceral organs.
Research in the last two decades has shown that despite
their apparent simplicity, sensory ganglia are the site of
neural information processing (Devor, 1999; Krames, 2015).
Although devoid of synapses, sensory neurons possess numerous
receptors for neurotransmitters and hormones and also release
neurotransmitters, such as glutamate, ATP, substance P, and
CGRP (Huang and Neher, 1996; Devor, 1999; Matsuka et al.,
2001; Huang et al., 2013). Thus, the neurons can communicate
FIGURE 1 | Diagram showing the sensory innervation of the
gastrointestinal (GI) tract. The GI tract sends afferents to spinal cord by
spinal nerves via dorsal root ganglia (DRG), and vagal afferents, which
originate from neurons in the nodose/jugular ganglia and reach the brain stem.
among themselves and also with other cell types in the
ganglia, mainly glial cells (Amir and Devor, 1996; Oh and
Weinreich, 2002). Indeed, there is evidence for bidirectional
interactions between neurons and glial cells in these ganglia
(Suadicani et al., 2010; Huang et al., 2013), largely mediated
by purinergic P2 receptors and gap junctions (GJ), but the
significance and precise mechanisms of such communication is
still obscure.
It is well established that under pathological conditions
sensory neurons can generate spontaneous electrical activity,
and thus play an active role in chronic pain (Cherkas et al.,
2004; Devor, 2013; Hoeijmakers et al., 2015). It was reported
that the sensitivity of sensory neurons to ATP, acting on
purinergic P2X3 receptors (P2X3Rs; Zhou et al., 2001; Chen
et al., 2005), and to substance P (Xu and Zhao, 2001) is
increased in pain models, which may contribute to neuronal
sensitization. There is evidence that also in rodent models of
visceral pain DRG neurons undergo profound physiological
and pharmacological changes (Moore et al., 2002; King et al.,
2009; Beyak, 2010; Bielefeldt and Gebhart, 2013). Most notable
are the changes in the expression and function of Na+
channels, resulting in augmented Na+ currents, which partly
underlie the hyperexcitability of DRG neurons (King et al.,
2009; Bielefeldt and Gebhart, 2013). Decreased K+ currents
were also found to contribute to neuronal excitability in
models of visceral pain (Dang et al., 2004; Beyak, 2010),
leading to a greater excitability of sensory neurons and
to pain.
As mentioned above, visceral organs can cross-sensitize by
mechanisms believed to be due to convergence in spinal cord
neurons (Bolser et al., 1991; Qin et al., 2004; Brumovsky and
Gebhart, 2010), but the possibility of more distal contribution to
this effect has received little attention. However, neuron-neuron
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cross talk within DRG does exist (Devor and Wall, 1990; Amir
and Devor, 1996; Devor, 2013), suggesting that interactions at
the DRG level may contribute to referred pain. Moreover, there
is evidence for dichotomizing DRG neurons, with an axon that
bifurcates and sends one branch to the colon, and the other to the
bladder, which may account for referred pain between these two
organs (Christianson et al., 2007). Another study showed that up
to 40% of the axons of T3–T8 DRG neurons in rats dichotomize
to both duodenum and pancreas (Li et al., 2013); for a review, see
Brumovsky and Gebhart (2010). Still, direct functional evidence
for the role of DRG in referred pain is lacking.
NEURON-GLIA INTERACTIONS IN PAIN
It has been found that glial cells (astrocytes and microglia) in
the spinal cord undergo activation (reactive gliosis) following
peripheral injury in animal models of chronic pain, suggesting
the involvement of these cells in pain. This has led Watkins and
her colleagues to state that the frequent failure of the available
therapies for chronic pain is due to the emphasis on neurons as
the target for analgesic drugs. They proposed that glial cells could
be a better target for pain therapy (Watkins and Maier, 2002).
Recent studies have provided firm support for this idea (Ji et al.,
2013; Tsuda et al., 2013a,b). We suggested that not only central
glial cells are involved in pain generation and maintenance, but
also satellite glial cells (SGCs) in sensory ganglia play such a role
(Hanani et al., 2002; Huang et al., 2010).
It has been stated that ‘‘changes in the excitability of primary
nociecptive afferents are the single most important factor in
the generation and maintenance of chronic neuropathic pain
in humans’’ Scadding and Koltzenburg (2013). This conclusion
holds also for central sensitization, because it is driven by
peripheral changes. It is established that neuronal activity inDRG
depends to a large degree on neuron-glia interactions (Hanani,
2012; Huang et al., 2013; Ji et al., 2013). Therefore learning on
these interactions is essential for full understanding all types of
pain, including visceral pain.
Neurons in sensory ganglia are surrounded completely by a
tight envelope of SGCs, and it was proposed that the neurons and
their surrounding SGCs form a distinct functional unit (Hanani,
2005), see Figure 2. The gap between the neurons and SGCs
is only 20 nm, and therefore the neuronal extracellular space
is very small, which enables a tight control of the neuronal
environment by the SGCs (and neurons). The SGCs sheath
around a given neuron is complete, but is permeable even
to large molecules, such as proteins (for review, see Hanani,
2005). Still, as SGCs are endowed with transporters for various
neuroactive molecules (Hanani, 2005; Jasmin et al., 2010), the
glial envelope can function at least as a partial barrier between the
circulation and the neurons. The DRG vasculature is fenestrated,
and therefore there is no blood-ganglion barrier (Hanani, 2005).
A subpopulation (1.6–9.4%, depending on species and age) of
DRG neurons are not surrounded by SGC sheath singly, but
two or more of neurons have a common glial cover, forming
an arrangement termed ‘‘cluster’’, (Pannese et al., 1991, 1993).
For reviews on SGCs (see Pannese, 1981, 2010; Hanani, 2005;
Takeda et al., 2009; Jasmin et al., 2010; Hanani, 2012; Hanani
FIGURE 2 | Low magnification electron micrograph of mouse DRG
showing the cell body of a sensory neuron (N1) enveloped by a
satellite glial cell (SGC) sheath, which was painted red. Note that the
entire outer contour of the sheath is smooth and is completely separated from
the sheaths encircling the adjacent nerve cell bodies (N2–N4) by the
connective tissue space (ct). The small empty regions within the SGCs
envelope are fine neuronal protrusions that increase the contact between the
two cell types (see Pannese, 2002). s, SGS; v, blood vessel. Scale bar, 4 µm.
and Spray, 2013; Huang et al., 2013; Ji et al., 2013). There is
considerable information on how SGCs are altered in models
of somatic and orofacial pain models (see references above),
but much less is known about these cells in models of visceral
pain. Below is an account of the current knowledge on this
topic.
SGCs AND PAIN IN PARTIAL COLONIC
OBSTRUCTION
Huang and Hanani (2005) reported that in a mouse model
of partial colonic obstruction, the threshold for withdrawal
response to mechanical stimulation of the abdominal skin
was markedly reduced compared with controls. It has been
established that this response is a reliable indication for GI
pain (Laird et al., 2001). We found by retrograde labeling
that the distal colon is innervated predominantly by S1 and
L1 DRG neurons, and these ganglia were selected for the in
vitro study. Intracellular electrical recordings from neurons in
ganglia obtained from mice after partial obstruction showed an
augmented frequency of spontaneous subthershold oscillations,
which are an important contributing factor in the generation
of neuronal hyperexcitability in pain models (Amir et al.,
1999; Devor, 2013). DRG neurons from obstructed mice also
displayed a greater degree of spontaneous action potentials,
which are likely to be due to the subthrehold oscillations.
Intracellular injection of the dye Lucifer yellow (which crosses
GJ) into individual SGCs showed that SGCs from DRG of
obstructed mice displayed augmented coupling via GJ (Huang
and Hanani, 2005). Most prominent was the increased coupling
between SGC envelopes around different neurons, which has
the potential to strengthen the communication between the
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neuron-SGC units. The augmented coupling was observed
in cells injected randomly throughout the ganglia, but when
dye was injected to SGCs near neurons projecting to the
distal colon, coupling between glial envelopes was over 3-fold
greater compared with random injection. As only 1–2%
of neurons in the ganglia project to the distal colon, the
effect of obstruction must have spread from directly-affected
neurons to non-affected ones, but still SGCs near neurons
directly affected displayed a greater degree of coupling. It
may be concluded that the affected neurons release factors
that can diffuse and influence neighboring cells. Such spread
of glial activation in sensory ganglia following peripheral
damage is well documented (e.g., Stephenson and Byers, 1995;
Thalakoti et al., 2007), but the released factors are not yet
known.
The nature of the injury in the obstruction model is not well-
defined, but it is probably associated with local inflammation
because the density of neutrophils was elevated within the colonic
muscles. Also, the colonic wall was thickened (both muscle and
mucosa) as found in models of intestinal inflammation in rats
(Eskandari et al., 1997; Moreels et al., 2001). These findings
suggested that inflammatory processes within the intestinal wall
triggered the changes in the DRG that contributed to chronic
pain. The observation of the increased SGC coupling led to
the suggestion that this and other changes in these cells may
contribute to augmented neuronal excitability and to GI pain
(Huang and Hanani, 2005).
SGCs IN COLONIC INFLAMMATION
The account above suggested a possible involvement of SGCs
in the events connecting the changes in the colon to neuronal
hyperexcitability in the obstruction model. We tested this
idea in a study where colonic inflammation was induced
by instilling dinitrobenzene sulfonic acid (DNBS) into the
lumen of the distal colon of mice (Huang et al., 2010). The
ganglia (S1 DRG, which innervate the distal colon) were
examined in vitro 10–12 days after DNBS application. First
we established that the DNBS-treated mice displayed tactile
hypersensitivity in response to stimulation of the abdominal
skin. As found in models of somatic (Hanani et al., 2002;
Dublin and Hanani, 2007) and orofacial (Cherkas et al., 2004)
pain and also in the obstruction model, dye coupling of
SGCs around different neurons was greatly augmented (by
FIGURE 3 | Inflammation-induced changes in dye coupling between SGCs in the vicinity of neurons that innervate the colon. (A) A micrograph showing
two DiI-labeled neurons (marked N1, N2), which innervate the colon. (B) An SGC (asterisk) near N1 was injected with LY. (C) Merged image obtained from (A) and
(B) showing the relationship between DiI-labeled neurons and LY-injected SGC. Note that the LY-injected SGC is coupled to other SGCs that ensheathe unlabeled
(presumably non-colonic) neurons. The images are of living cells during the injection experiment. Scale bar, 25 µm. (D) The histogram shows that SGCs coupling
increased after the induction of inflammation. The effect was much greater when the dye-injected SGCs were in the vicinity of the DiI-labeled neurons compared with
SGCs that were injected randomly throughout the ganglion. ∗p < 0.05, ∗∗p < 0.01. Modified from Huang et al. (2010).
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6.6-fold, Huang et al., 2010), see Figure 3. GFAP expression
in SGCs was upregulated by nearly 4-fold in this model
(Hanani and Belzer, 2014), see Figure 4. To learn about the
nature of the SGC coupling, we incubated the ganglia with
the gap junction blocker carbenoxolone, which blocked the
dye coupling, confirming that it was mediated by GJ. It is
known that carbenoxolone has various pharmacological actions
besides blocking GJ, and for further confirmation we used
(separately) two additional gap junction blockers, palmitoleic
acid and meclofenamic acid, which are chemically distinct from
carbenoxolone and from each other. Meclofenamic acid was
found to have some inhibitory actions on neurons (Peretz
et al., 2007), whereas there is no report on the direct effect
of palmitoleic acid in neurons. These blockers again inhibited
the dye coupling. The fact that all these three established
gap junction blockers have the same actions of neuronal
excitability is highly suggestive that their main effect was to
reduce neuronal excitability through the blockade of GJ. It
should be emphasized that the experiments were done in intact,
freshly isolated ganglia, where the SGC-neuron unit is not
disrupted, as may occur in isolated or cultured cells (see Belzer
et al., 2010). Using intracellular electrical recordings from S1
DRG neurons, we verified that 10–12 d after the induction
of colonic inflammation the neurons were hyperexcitable, as
evidenced by a lower depolarizing current that was needed to
evoke an action potential and by the increased spontaneous
activity (both subthreshold oscillations and spontaneous action
potentials).
We then asked whether the augmented SGC coupling and
the neuronal hyperexcitability were related causally, and to
answer this question we repeated the electrical recordings from
neurons in the presence of gap junction blockers. The results
showed that each of the three gap junction blockers mentioned
above was able to normalize the neuronal behavior (Figure 5).
That is, blocking SGC GJ restored neuronal excitability to
control level. As the experiment was done on isolated DRG,
the blockers must have acted directly on DRG cells (most
likely on SGCs). It should be added that DNBS also increased
neuron-neuron coupling; this was observed in only 12.1% of
the neurons (compared with 0.7% in controls), but could have
contributed to the overall effect. Neuron-SGC coupling has
been reported for rat TG after application of capsaicin to
the neuronal terminals in the skin (Thalakoti et al., 2007).
We observed neuron-SGC coupling in only 1.6% of the cases
in treated animals, but this is probably an underestimate
because of the difficulty in detecting such coupling. Finally
we asked whether blocking GJ in behaving mice could reduce
the abdominal tactile hypersensitivity (which reflects colonic
pain). We injected (i.p.) each of the three gap junction
blockers (separately) 1 h before testing pain behavior, and
found that this elevated the threshold in DNBS-treated mice,
consistent with an analgesic effect of the blockers. As the
gap junction blockers were injected systemically, the site of
their action could not be determined, but there is evidence
that carbenoxolone and meclofenamic acid are hydrophilic,
and are unlikely to cross the blood brain barrier, which
was directly confirmed for carbenoxolone (Leshchenko et al.,
2006). To address this point we showed in a subsequent
study that in DRG that were removed from animals injected
i.p. with carbenoxolone, the GJ (induced in a pain model)
were still blocked (Warwick and Hanani, 2013). This was
interpreted as an evidence that carbenoxolone injected i.p.
binds to SGCs and that the binding and the gap junction
blockade persisted even after the removal of the ganglia from
the body.
Another study on the effect of colonic inflammation was
carried out by Song et al. (2014), who induced colonic
inflammation in rats with 2, 4, 6, trinitrobenzene sulfonic acid
(TNBS). They reported that 4 d after TNBS administration,
GFAP immunostaining in SGCs was greatly augmented,
consistent with SGC activation. TNF-α RNA level in DRG
L6-L2 was elevated by 50%, and protein level increased by
84%. Similar changes in cytokines were observed previously
in DRG (Huang et al., 2013) and TG, (Takeda et al., 2009).
Song et al. claimed that the TNF was located in SGCs, but
this requires further verification. Electrical stimulation of the
axons of sensory neurons caused an increase of over 3-fold
in the level of TNF-α in the bathing medium, indicating
the release of this cytokine from the ganglion (presumably
from SGCs). However, as TNF-α was believed to be present
in the SGCs, it is not clear how neuronal firing led to the
release of this cytokine, although it is possible to conceive a
chain of events that can mediate this effect. Obviously, much
remains to be done on this topic, and the main importance
FIGURE 4 | Glial fibrillary acidic protein (GFAP) expression is increased in SGCs in dorsal root ganglion DRG of dinitrobenzene sulfonic acid
(DNBS)-treated mice. (A) Control. (B) The labeling of SGCs for GFAP 10–12 days following colonic inflammation was greatly increased. (C) Quantitation of GFAP
expression in SGCs in DRG from controls and from DNBS treated animals (12 d colitis). The upregulation of GFAP indicates the activation of SGCs. ∗p < 0.05.
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FIGURE 5 | The effect of gap junction blockers on the electrophysiological properties of neurons in mouse S1 DRG after colonic inflammation. Ten to
twelve days after the induction of inflammation, the proportion of the neurons with spontaneous action potentials (A) and spontaneous potential oscillations
(B) increased, and also there was a decrease in the threshold for firing an action potential (C). All the three gap junction blockers, carbenoxolone (50 µM),
meclofenamic acid (100 µM) and palmitoleic acid (30 µM), applied separately, effectively reversed the neuronal hyperexcitability induced by the colonic inflammation.
The comparisons are between data obtained for the DNBS-treated mice and data obtained for the other experimental groups. ∗p < 0.05, ∗∗p < 0.01, Fisher’s exact
test. Modified from Huang et al. (2010).
of this and related studies is to stimulate more interest in
the potential role of neuron-SGCs interactions in GI pain. In
another study on rats, Kannampalli et al. (2014) used TNBS
to induce colonic inflammation and measured pain reactions
electrophysiologically in response to colo-rectal distension.
They found that following TNBS application both SGCs in
DRG and microglia in the spinal cord were activated. Drugs
known to inhibit glial activation (minocycline for microglia,
and arabinofuranosyl cytidine for both microglia and SGCs),
reduced pain reactions. This work again supports the idea
that glial activation is a crucial element in the generation
and maintenance of visceral pain, and that these cells can
be an effective therapeutic target. Overall, the results from
work on rats is in agreement with those on mice, supporting
the general conclusion that SGCs in DRG are activated
by colonic inflammation and might contribute to GI pain.
Moreover, it appears that the changes that SGCs undergo in
the GI pain models are quite similar to those observed in
somatic and orofacial pain models. This suggests that despite
the considerable diversity of pain syndromes and manifold
pathways and mediators, the changes in sensory ganglia may
be rather invariable, offering a generalized approach to therapy.
Furthermore, it could be speculated that the proposed role
of SGCs in GI pain, can be generalized to other types of
visceral pain, but to establish this, further experimental work is
required.
THE ROLE OF CALCIUM WAVES IN
GLIA-NEURON INTERACTIONS
We still know little on how SGC activation contributes to
neuronal hyperexcitability, but it seems that the key to this
question lies in a better understanding of the bidirectional
neuron-SGC interactions. As little work has been done on
this topic in relation to GI pain, most on the information
must be derived from work on somatic and orofacial pain.
A major mode of intercellular communication in sensory
ganglia is chemical, and it was suggested that enhanced
release of mediators (ATP, cytokines, glutamate, and others)
after injury is an important factor in nociception (Takeda
et al., 2009; Huang et al., 2013). A major mechanism of
signal propagation within the glial network is intercellular
calcium waves (ICW; Scemes and Giaume, 2006). ICW have
been studied intensively in the CNS and it is established
that they are mediated by both GJ and chemical mediators,
most notably ATP (Scemes and Giaume, 2006). Channels,
like pannexin1 (Iglesias et al., 2009), connexin hemichannels
(Orellana and Stehberg, 2014), and P2X7 purinergic receptors
(Baroja-Mazo et al., 2013), which allow the release of ATP
and other mediators are likely to play a role as well. The only
available information on ICW in sensory ganglia is from a
study on TG cultures containing SGC and neurons (Suadicani
et al., 2010), which showed that both GJ and the release of
ATP from both neurons and SGCs are involved. We have
suggested a model that incorporates these ideas to explain
how enhanced ICW contribute to neuronal hyperexcitability
in pain models (Kushnir et al., 2011; Hanani, 2012), see
Figure 6.
NODOSE GANGLIA AND PAIN
Vagal afferents innervate internal organs such as the heart,
respiratory tract, and most of the GI tract (Browning and
Mendelowitz, 2003; Undem and Weinreich, 2005; Li, 2007).
The cell bodies of the sensory neurons that give rise to these
afferents are located in the nodose and jugular ganglia. In
mice and rats these two ganglia are fused and referred to as
NG. A well known function of vagal afferents is to mediate
reflexes such as swallowing, vomiting, and coughing (Undem
and Weinreich, 2005). Another function of the vagi is the
inflammatory reflex by which central vagal circuits are activated,
leading to an attenuation of inflammatory processes (Pavlov and
Tracey, 2012). The vagi appear to contribute to pain sensation in
a complex manner (Jänig, 2005). On one hand, vagal activation
leads to visceral pain, e.g., angina pectoris (Rosen, 2012) and
pancreatic pain (Schwartz et al., 2013). Also, vagal afferent are
important for pain associated with chemoreception, like sensing
acidic pH and the presence of bile acids in the upper GI
tract (Bielefeldt and Gebhart, 2013; Holzer, 2015). The electrical
activity of vagal afferents was found to increase following injury
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FIGURE 6 | Schematic diagram describing the proposed relations
between SGCs and neurons in sensory ganglia, and the consequences
of peripheral insults. The axon of neuron one had been exposed to local
injury, which causes various changes in the neuronal soma. One such change
is increased firing of action potentials, which induces ATP release from the
neuron and activates P2 receptors on SGCs surrounding the neuron, and on
the neuron itself, causing an increase in [Ca2+]in in these cells. Because of the
enhanced sensitivity of SGCs to ATP (Blum et al., 2014; and
Feldman-Goriachnik et al., 2015), this action will be augmented, and the
higher level of [Ca2+]in will lead to a greater release of ATP from the cells
(Suadicani et al., 2010). ATP released from the SGCs and neuron, in
combination with the augmented communication by gap junctions (GJ)
following inflammation, will cause an increased spread of Ca2+ waves to a
neighboring neuron (Neuron 2, which was not affected directly by the injury),
and its surrounding SGCs (see Suadicani et al., 2010). The Ca2+ waves
activate these cells, and the overall effect will be a greater neuronal excitation.
This model can explain how peripheral injury can increase excitability of a large
number of sensory neurons, which may contribute to chronic pain. The model
is consistent with observations on the effects of insults in somatic, orofacial
and visceral tissues.
to the stomach (Miranda et al., 2009), which might be associated
with vagal-mediated pain. On the other hand, vagal activation
can reduce somatic pain via central pathways (Miao et al.,
2000; Jänig, 2005), and this is correlated with inhibitory actions
of vagal afferents on spinothalamic neurons (Chandler et al.,
1991).
SGCs IN NODOSE GANGLIA
The effects of GI tract inflammation on NG neurons has been
studied by several groups (for example, Bielefeldt et al., 2002a,b;
De Jonge et al., 2003; Dang et al., 2005; Banerjee et al., 2007;
Hu et al., 2014). Overall, it appears that GI inflammation
increases the excitability of NG neurons. Neurons in the NG,
like in other sensory ganglia, are surrounded by SGCs. The
few studies on this topic show that SGCs in NG are quite
similar to those in other sensory ganglia. There is evidence
for orexin receptors in SGCs in rat and human NG (Burdyga
et al., 2003) and for BDNF receptors on SGCs in NG of rats
(Wetmore and Olson, 1995). A calcium imaging study has
shown that SGCs in rat NG are sensitive to glutamate and
to ATP (via P2YR) and can release GABA (Shoji et al., 2010;
Yokoyama et al., 2015). These authors claimed that GABA
release from SGCs onto nodose neurons can inhibit neuronal
activity. However, there is no evidence for GABA synthesis in
SGCs in TG (see Vit et al., 2009), although infection of rat
SGCs with GAD65, an enzyme that synthesizes GABA, led to
inhibitory actions mediated by GABA release from SGCs on
neurons (Vit et al., 2009). A calcium imaging study on cultured
rat NG cells has shown that glial cells (presumed to be SGCs)
respond to cholecystokinin (CCK, 1 µM), ghrelin, and leptin
100 nM (Avau et al., 2013). In our preliminary study on mouse
SGCs in intact ganglia, where the identity of the cells is not
in doubt, SGCs did not respond to leptin (10 nM) or to CCK
(1 µM).
The only available study on changes in nodose SGCs in a
pain model is by Feldman-Goriachnik et al. (2015), who induced
systemic inflammation in mice by a single i.p. injection of the
endotoxin lipopolysaccharide (LPS). This treatment induces pain
and also causes profound changes in SGCs in DRG (Blum et al.,
2014). The changes induced in nodose SGCs were very similar
to those observed in DRG after the same treatment, which
included augmented dye coupling between SGCs surrounding
different neurons and upregulation of GFAP in SGCs. Also,
calcium imaging showed that LPS caused increased sensitivity
of SGCs to ATP, largely by upregulating responses via P2X
receptors (mostly P2X2 and P2X7), as found for SGCs in
TG following local inflammation (Kushnir et al., 2011). The
expression of pannexin1 in SGCs in rat NG neurons has been
described by Retamal et al. (2014), and we found that LPS
induced a 2-fold increase in pannexin1 expression in SGCs in
NG of mice (Feldman-Goriachnik et al., 2015), These changes
persisted for up to 14 d after LPS injection. The possible
correlation between these changes and the behavior of NG
neurons has not been determined yet, but by analogy with
studies on other sensory ganglia, it can be expected that the
changes associated with SGC activation will augment neuronal
excitability. It may be proposed that the model described
above (Figure 6), which is based on augmented calcium waves,
leading to greater neuronal excitation in pain models, also
applies to NG, but experimental work to test this idea is
required.
Altering vagal function has some important implications. In
recent years vagus nerve stimulation (VNS) has been used to
treat various serious neurological diseases (Hays et al., 2013) and
also somatic (Kirchner et al., 2006) and GI pain (Chen et al.,
2008) andmigraine (Goadsby et al., 2014). If the electrical activity
of vagal afferents can be controlled by altering SGC-neuron
interactions using drugs, this could replace VNS, which requires
the implanting of electrodes. Clearly, further research on SGCs in
the NG in rodents and also in higher species is of great interest.
SATELLITE GLIAL CELLS IN
SYMPATHETIC GANGLIA
The sympathetic nervous system has been implicated in a
variety of pain syndromes, and in particular complex regional
pain syndrome (CRPS; Jänig, 2010; Schlereth et al., 2014).
Peripheral injury induces the sprouting of sympathetic fibers
in DRG (McLachlan et al., 1993), which may act as a link
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between the pain and sympathetic pathways. SGCs may be
involved in this pathway, as it was found that in a colonic
inflammation model, numerous SGCs contained the enzyme
tryosine hydroxylase, which synthesizes norepinephrine
(Xia et al., 2011). Neurons in paravertebral and prevertebral
sympathetic ganglia are surrounded by SGCs that are rather
similar to those in DRG (Hanani, 2010). The GI tract is
supplied by sympathetic fibers from prevertebral ganglia,
but very little research has been devoted to changes in
SGCs in any sympathetic ganglia. We have shown that
10 d after colonic application of DNBS in mice, coupling
among SGCs surrounding different neurons in prevertebral
ganglia (superior mesenteric ganglia) increased by over
14-fold (Hanani et al., 2010). This adds to the evidence
that SGCs in sympathetic ganglia can be activated by
injury (Hanani, 2010). In analogy with the contribution
of SGC activation to excitation of DRG neurons, it can
be hypothesized that activation of SGCs in sympathetic
ganglia contributes to excitation of sympathetic neurons,
thereby augmenting sympathetic outflow into the pain
pathways.
CONCLUSIONS
It is now established that SGCs in sensory ganglia, like glial cells
in the spinal cord, undergo activation in pain models and are an
essential element within the pain pathways. Most of the available
information on SGCs derives fromwork on somatic and orofacial
painmodels, but several recent studies have shown that inmodels
of colonic inflammation SGCs in DRG are activated as well.
This activation, and the functional changes that occur in SGCs
apparently participate in the processes that augment neuronal
activity, and therefore these cells are likely to contribute to GI
pain. It will be interesting to explore this idea in animal models
of inflammation in other parts of the GI tract. As cells in DRG
are exposed to the circulation, SGCs could be an effective target
for the treatment GI pain.
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